Easton Pharmaceuticals, Inc. (EAPH)

[mckinley1]

EAPH own's iBliss 100%.

Easton previously executed a closing agreement with iBliss Inc. of Toronto to acquire 100% of its vaporizer business which was generating approximately $15,000,000 CDN in revenues 3 years ago. Due to the fact Easton made the decision to first close and allocate funds towards the acquisition and agreement with Alliance Group, Easton has not consolidated its financial statements with that of iBliss and their revenues until a required cash payment has been advanced. However, Easton is now putting its efforts on iBliss and this acquisition, which includes a restructuring of the agreement. Both companies are working towards a consolidation of iBliss's revenues which may coincide with the acquisition of another vaporizer company based out of England that currently generates approximately $6,000,000 Euros with healthy profit margins.